|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
12/6/2012 7:40:41 AM
A Windsor pharmaceuticals plant will shut down in about six months, putting 32 people out of work. Sunovion Pharmaceuticals Inc. of Marlborough, Mass., said Wednesday its Sepracor Canada (Nova Scotia) Ltd. plant will cease operations near the middle of 2013. “Over the past decade, the industry has seen a shift in the manufacturing market dynamics for active pharmaceutical ingredients,” Vince Kosewski, the plant’s general manager, said Wednesday in an email. “The difficult decision to close our Windsor, Nova Scotia, plant is critical to our business strategy to remain competitive.” The company said in a news release earlier in the day it was making transition arrangements for affected employees. “This action will not affect Sunovion’s Canadian sales operation or the ability to develop or sell our medications in Canada.” Workers in Windsor were receiving news of the shutdown Wednesday, corporate spokeswoman Candace Steele Flippin said from Marlborough. “It is an unfortunate situation.” Sepracor Canada (Nova Scotia) Ltd. is an indirect subsidiary of Sunovion Pharmaceuticals.
|
|
|
|
|
|
|
|
|
|
|